|
HNRNPD expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.850000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.157000E-01 |
| Normal-vs-Stage2 |
7.589400E-01 |
| Normal-vs-Stage3 |
2.263200E-01 |
| Normal-vs-Stage4 |
7.093800E-01 |
| Stage1-vs-Stage2 |
8.184600E-01 |
| Stage1-vs-Stage3 |
5.591000E-01 |
| Stage1-vs-Stage4 |
9.167000E-01 |
| Stage2-vs-Stage3 |
5.054800E-01 |
| Stage2-vs-Stage4 |
9.487600E-01 |
| Stage3-vs-Stage4 |
5.984600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.594200E-01 |
| Normal-vs-AfricanAmerican |
8.590600E-01 |
| Normal-vs-Asian |
6.757500E-02 |
| Caucasian-vs-AfricanAmerican |
3.991400E-01 |
| Caucasian-vs-Asian |
2.626300E-02 |
| AfricanAmerican-vs-Asian |
1.083880E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.983600E-01 |
| Normal-vs-Female |
8.143600E-01 |
| Male-vs-Female |
2.153600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.580600E-01 |
| Normal-vs-Extreme_Weight |
5.681000E-01 |
| Normal-vs-Obese |
9.120800E-01 |
| Normal-vs-Extreme_Obese |
1.123840E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.446200E-01 |
| Normal_Weight-vs-Obese |
8.662800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.147000E-01 |
| Extreme_Weight-vs-Obese |
4.732400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.395400E-01 |
| Obese-vs-Extreme_Obese |
1.457990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.521200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.716000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.983000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.761020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.344000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.360040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.136300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.986760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.167400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.388200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.101800E-01 |
| Normal-VS-Type2 PRCC |
5.433900E-04 |
| Normal-VS-KIRP CIMP |
3.449000E-01 |
| Normal-VS-Unclassified PRCC |
6.985600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.2687000001429E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.240400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.212000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.043800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.243800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.545800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.173900E-02 |
| Normal-vs-N1 |
4.277600E-01 |
| Normal-vs-N2 |
2.500600E-01 |
| N0-vs-N1 |
5.516500E-03 |
| N0-vs-N2 |
9.172800E-01 |
| N1-vs-N2 |
1.867770E-01 |
|
|
